Building a Research Career in Colorado: Insights from an Inaugural Boettcher Investigator
For Robin Dowell, D.Sc., Professor of Molecular, Cellular and Developmental Biology at the University of Colorado Boulder BioFrontiers Institute, Colorado offers the right environment for a bold, interdisciplinary scientific career. Her research merges genetics and computer science to investigate transcriptional
Onconaut Therapeutics Advances Precision Oncology from the University of Colorado Anschutz
For Dan LaBarbera, Ph.D., founder and CEO of Onconaut Therapeutics, Colorado provides the momentum and support needed to accelerate first- and best-in-class cancer therapies rooted in decades of scientific discovery. As Professor and Director of the CU Anschutz Center for Drug
Umoja Biopharma’s Colorado Momentum
The mission-driven team at Umoja Biopharma is advancing next-generation in vivo CAR T therapies. Recently named as “Company of the Year” at Colorado BioScience Association's 22nd Annual Awards Celebration Presented by AGC Biologics, Umoja’s Colorado footprint includes the CLIMB, a
EnteroTrack Founder Robin Shandas, Ph.D., Transforms GI Biopsies at Fitzsimons Innovation Community
For Robin Shandas, Ph.D., innovation begins with listening to physicians and patients who are frustrated by repeat biopsies and eager for relief. The bioengineer and entrepreneur, a Distinguished Professor of Bioengineering at University of Colorado Denver’s Department of Bioengineering, part
Bringing Life Sciences Innovators Home to Colorado
Fitzsimons Innovation Community brings you a new tool, our just-released eBook, entitled Bringing Life Sciences Innovators Home to Colorado. This is a resource for life sciences companies who are considering building or relocating to Colorado. Consider this eBook a guide
How a Serial Entrepreneur Plans to Bring Biotech Innovation Hubs to Colorado
When Afshin Safavi moved to Colorado with his wife and two daughters in 2016, he intended to retire. The serial entrepreneur and veteran biochemist had spent the first ten years of his career working for innovative pharmaceutical companies like Bayer,